Get Live Data

PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

  2. Share Prices
  3. ORPH.L Share Price
  4. ORPH.L Share Regulatory News
  5. Director's Dealing

Pin to quick picksORPH.L Regulatory News (ORPH)

ORPH.L Information
  • There is currently no data for ORPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director's Dealing

27 May 2014 14:26

RNS Number : 1425I
Venn Life Sciences Holdings PLC
27 May 2014
 



27 May 2014 Venn Life Sciences Holdings Plc

("Venn" or the "Company")

 

Director's Dealing

 

 

Venn Life Sciences (AIM: VENN), a growing Clinical Research Organisation (CRO) providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, announces that David Evans, a director, has today purchased 210,000 ordinary shares of 0.1 pence each in the Company at a price of 20.5 pence per share.

David Evans now holds 289,033 ordinary shares of 0.1 pence each, representing 1.03 per cent. of the Company's issued share capital.

 

 Enquiries:

 

Venn Life Sciences Holdings Plc

Tony Richardson, Chief Executive Officer

Tel: +353 154 99 341

 

Zeus Capital Limited (Nominated Adviser and Broker)

Ross Andrews/Andrew Jones (Corporate Finance)

Tel: 0161 831 1512

Dominic Wilson (Institutional Sales)

 

Tel: 020 7533 7727

Walbrook PR Ltd

 

Paul McManus

Tel: 020 7933 8787 or venn@walbrookpr.com

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBXGDUXDDBGSR
123456789
Date   Source Headline
28th Sep 20167:00 amRNSHalf-year Report
22nd Sep 20167:00 amRNSAppointment of Non Executive Director
13th Sep 20167:00 amRNSDirectorate Change
24th Aug 20167:00 amRNSNotice of Results
3rd Aug 20167:00 amRNSContract wins
30th Jun 201612:18 pmRNSResult of AGM
30th Jun 20167:00 amRNSAGM Statement
20th Jun 20164:24 pmRNSShareholder notification
10th Jun 201611:05 amRNSPosting of Annual Report and Notice of AGM
10th May 20167:00 amRNSFinal Results
24th Mar 20167:00 amRNSYear End Update
18th Jan 20168:00 amRNSEnterprise Securities Market Notice
13th Jan 20167:00 amRNSESM Schedule 1 update
13th Jan 20167:00 amRNSESM Appendix to Schedule 1 update
12th Jan 20167:00 amRNSContracts worth EUR 3.4m signed with US Biotech
8th Jan 20162:03 pmRNSHolding(s) in Company
8th Jan 20167:01 amRNSTrading update
8th Jan 20167:00 amRNSDirectorate Change
11th Dec 20157:00 amRNSChange of Adviser
11th Dec 20157:00 amRNSAppendix to Schedule 1 announcement
11th Dec 20157:00 amRNSESM Pre-Admission Announcement
3rd Nov 20157:00 amRNSGrant of Share Option & Total Voting Rights
23rd Oct 20157:00 amRNSContract for over EUR1m with French Biotech
19th Oct 20157:00 amRNSAppointment of Director
19th Oct 20157:00 amRNSCompletion of the Acquisition of Kinesis Pharma BV
9th Oct 201511:38 amRNSResult of General Meeting & Update on Acquisition
22nd Sep 20157:01 amRNSHalf Yearly Report
22nd Sep 20157:00 amRNSProposed acquisition & Placing
24th Aug 20152:00 pmRNSAppointment of Co-Broker
21st Aug 20157:00 amRNSNotice of Results
13th Aug 20157:00 amRNSTrading update
30th Jun 201511:39 amRNSResult of AGM
30th Jun 20157:00 amRNSAGM Statement
15th Jun 20157:00 amRNSAppointment of Chief Financial Officer
10th Jun 20153:46 pmRNSEUR 2m contract with leading European biotech
28th May 201510:14 amRNSPosting of Annual Report & Notice of AGM
22nd May 20157:00 amRNSFinal Results
20th May 20153:29 pmRNSHolding(s) in Company
20th May 20157:00 amRNSNew services from Innovenn
12th May 20157:01 amRNSDirectorate Change
8th Apr 20159:06 amRNSHolding(s) in Company
8th Apr 20159:05 amRNSHolding(s) in Company
7th Apr 20152:39 pmRNSHolding(s) in Company
7th Apr 201511:17 amRNSHolding(s) in Company
2nd Apr 20152:00 pmRNSInvestor teach-in
2nd Apr 20157:00 amRNSInnoVenn expands products and first sales in US
1st Apr 201512:14 pmRNSResult of General Meeting
30th Mar 20157:00 amRNSContracts for EUR4.1m with US Biotech client
13th Mar 20154:45 pmRNSPlacing to raise £2 million
6th Mar 20157:00 amRNSChange of Registered Office
123456789

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.